APO RESEARCH · REPORT
Glycomics & Glycobiology
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Product & engineering
Understand the product.
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
Selected research
Industry Research
Glycomics & Glycobiology Industry Research Report 2026
Market perspective
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
Read the full market overview
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Scope
This report quantifies the global Glycomics & Glycobiology market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Glycomics & Glycobiology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glycomics & Glycobiology Market by Company
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA
Glycomics & Glycobiology Segment by Type
Instruments
Enzymes
Reagents
Kits
Glycomics & Glycobiology Segment by Application
Drug Discovery & Development
Diagnostics
Others
Glycomics & Glycobiology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Glycomics & Glycobiology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Enzymes
- Reagents
- Kits
Applications
- Drug Discovery & Development
- Diagnostics
- Others
Companies covered
- ThermoFisher Scientific
- Danaher
- Shimadzu Corporation
- ProZyme
- Takara Bio, Inc.
- Agilent Technologies
- Bruker
- Promega
- Waters Corporation
- R&D Systems
- New England Biolabs
- Merck KGaA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Glycomics & Glycobiology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Instruments
- 2.2.3 Enzymes
- 2.2.4 Reagents
- 2.2.5 Kits
- 2.3 Glycomics & Glycobiology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Discovery & Development
- 2.3.3 Diagnostics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Glycomics & Glycobiology Breakdown Data by Type
- 3.1 Global Glycomics & Glycobiology Historic Market Size by Type (2021-2026)
- 3.2 Global Glycomics & Glycobiology Forecasted Market Size by Type (2027-2032)
4 Glycomics & Glycobiology Breakdown Data by Application
- 4.1 Global Glycomics & Glycobiology Historic Market Size by Application (2021-2026)
- 4.2 Global Glycomics & Glycobiology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Glycomics & Glycobiology Market Perspective (2021-2032)
- 5.2 Global Glycomics & Glycobiology Growth Trends by Region
- 5.2.1 Global Glycomics & Glycobiology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Glycomics & Glycobiology Historic Market Size by Region (2021-2026)
- 5.2.3 Glycomics & Glycobiology Forecasted Market Size by Region (2027-2032)
- 5.3 Glycomics & Glycobiology Market Dynamics
- 5.3.1 Glycomics & Glycobiology Industry Trends
- 5.3.2 Glycomics & Glycobiology Market Drivers
- 5.3.3 Glycomics & Glycobiology Market Challenges
- 5.3.4 Glycomics & Glycobiology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Glycomics & Glycobiology Players by Revenue
- 6.1.1 Global Top Glycomics & Glycobiology Players by Revenue (2021-2026)
- 6.1.2 Global Glycomics & Glycobiology Revenue Market Share by Players (2021-2026)
- 6.2 Global Glycomics & Glycobiology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Glycomics & Glycobiology Head Office and Area Served
- 6.4 Global Glycomics & Glycobiology Players, Product Type & Application
- 6.5 Global Glycomics & Glycobiology Manufacturers Established Date
- 6.6 Global Glycomics & Glycobiology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Glycomics & Glycobiology Market Size (2021-2032)
- 7.2 North America Glycomics & Glycobiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Glycomics & Glycobiology Market Size by Country (2021-2026)
- 7.4 North America Glycomics & Glycobiology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Glycomics & Glycobiology Market Size (2021-2032)
- 8.2 Europe Glycomics & Glycobiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Glycomics & Glycobiology Market Size by Country (2021-2026)
- 8.4 Europe Glycomics & Glycobiology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Glycomics & Glycobiology Market Size (2021-2032)
- 9.2 Asia-Pacific Glycomics & Glycobiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Glycomics & Glycobiology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Glycomics & Glycobiology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Glycomics & Glycobiology Market Size (2021-2032)
- 10.2 South America Glycomics & Glycobiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Glycomics & Glycobiology Market Size by Country (2021-2026)
- 10.4 South America Glycomics & Glycobiology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Glycomics & Glycobiology Market Size (2021-2032)
- 11.2 Middle East & Africa Glycomics & Glycobiology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ThermoFisher Scientific
- 12.1.1 ThermoFisher Scientific Company Information
- 12.1.2 ThermoFisher Scientific Business Overview
- 12.1.3 ThermoFisher Scientific Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
- 12.1.5 ThermoFisher Scientific Recent Developments
- 12.2 Danaher
- 12.2.1 Danaher Company Information
- 12.2.2 Danaher Business Overview
- 12.2.3 Danaher Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.2.4 Danaher Glycomics & Glycobiology Product Portfolio
- 12.2.5 Danaher Recent Developments
- 12.3 Shimadzu Corporation
- 12.3.1 Shimadzu Corporation Company Information
- 12.3.2 Shimadzu Corporation Business Overview
- 12.3.3 Shimadzu Corporation Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
- 12.3.5 Shimadzu Corporation Recent Developments
- 12.4 ProZyme
- 12.4.1 ProZyme Company Information
- 12.4.2 ProZyme Business Overview
- 12.4.3 ProZyme Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
- 12.4.5 ProZyme Recent Developments
- 12.5 Takara Bio, Inc.
- 12.5.1 Takara Bio, Inc. Company Information
- 12.5.2 Takara Bio, Inc. Business Overview
- 12.5.3 Takara Bio, Inc. Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
- 12.5.5 Takara Bio, Inc. Recent Developments
- 12.6 Agilent Technologies
- 12.6.1 Agilent Technologies Company Information
- 12.6.2 Agilent Technologies Business Overview
- 12.6.3 Agilent Technologies Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
- 12.6.5 Agilent Technologies Recent Developments
- 12.7 Bruker
- 12.7.1 Bruker Company Information
- 12.7.2 Bruker Business Overview
- 12.7.3 Bruker Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.7.4 Bruker Glycomics & Glycobiology Product Portfolio
- 12.7.5 Bruker Recent Developments
- 12.8 Promega
- 12.8.1 Promega Company Information
- 12.8.2 Promega Business Overview
- 12.8.3 Promega Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.8.4 Promega Glycomics & Glycobiology Product Portfolio
- 12.8.5 Promega Recent Developments
- 12.9 Waters Corporation
- 12.9.1 Waters Corporation Company Information
- 12.9.2 Waters Corporation Business Overview
- 12.9.3 Waters Corporation Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
- 12.9.5 Waters Corporation Recent Developments
- 12.10 R&D Systems
- 12.10.1 R&D Systems Company Information
- 12.10.2 R&D Systems Business Overview
- 12.10.3 R&D Systems Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
- 12.10.5 R&D Systems Recent Developments
- 12.11 New England Biolabs
- 12.11.1 New England Biolabs Company Information
- 12.11.2 New England Biolabs Business Overview
- 12.11.3 New England Biolabs Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
- 12.11.5 New England Biolabs Recent Developments
- 12.12 Merck KGaA
- 12.12.1 Merck KGaA Company Information
- 12.12.2 Merck KGaA Business Overview
- 12.12.3 Merck KGaA Revenue in Glycomics & Glycobiology Business (2021-2026)
- 12.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
- 12.12.5 Merck KGaA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst